Assistant Professor of Gynecologic Oncology @PennMedicine @PennCancer | Physician-Scientist | 🇪🇺🇬🇷➡️🇺🇸 | Opinions expressed are my own.
Joined February 2020
- Tweets203
- Following1K
- Followers1.2K
- Likes1.6K
Dimitrios Nasioudis retweeted
Giants in Obstetrics and Gynecology: A Profile of David M. Gershenson, MD: a pioneer in the diagnosis, characterization, and treatment of low-grade serous neoplasms - MD Anderson Department of Gyn Oncology & Reproductive Medicine (David in back row center) ow.ly/AykH50Z8ntM
Dimitrios Nasioudis retweeted
De-escalation in Stage IC epithelial ovarian cancer—can we safely do less? 🤔
🔬 Histology-driven decisions
🟢 Safe omission possible in select subtypes
⚖️ Balance survival benefit vs toxicity
🤝 Shared decision-making is essential
Not all Stage IC needs chemo — precision matters.
🔗 bit.ly/4m5MdGY
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @RParejaGineOnco @lchiv4 @annafagottimd @HousseinELHAJJ3 @AinhoaMada @luribero26 @beatesarta @AlwynDO @PeppeParisi_ @ilkerselcukmd @VinTarantino @NSeminario27498 @dranushak88
#IJGConline #Research #Prevention #Treatment #Diagnostic #GynCancer #GynOnc #WomenHealth #SoMe #SoMe4GynOnc
Dimitrios Nasioudis retweeted
🚨 @US_FDA has approved pembrolizumab plus paclitaxel with or without bevacizumab for PD-L1+ PROC based on significant efficacy improvements in a phase 3 trial, marking an important milestone for the treatment.
Full details 📈: hubs.ly/Q0436BxS0
#ovca #oncology
Dimitrios Nasioudis retweeted
ADCs: guided missiles, slow chemo infusion, or something else? In our latest free-access commentary, led by Matthew Vogel and just out in @JCO_ASCO, we review the latest evidence on ADCs’ mechanism of action, diving deep into their fascinating complexity. ascopubs.org/doi/10.1200/JCO…
Dimitrios Nasioudis retweeted
Excited to share the Ovarian Cancer Research Syndicate line-up for the fall. Please share. We have amazing trainees presenting and the latest from leaders in the field.
@bitlerlabucd @DiFeoLab @WAGO_org @ocrahope @BasserBRCA @TheWistar @airdlab @OvCaAcademy @DNasioudis @achuthz
Dimitrios Nasioudis retweeted
#IJGCconversations Lymphadenectomy in Low-Grade #OvarianCancer with Elizabeth Tubridy and Dimitrios Nasioudis @DNasioudis
🎙️ bit.ly/44Gtz1f
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @HelenaObermair @sofiabigardiGMD @marina_rosanu @ChakraRim @FilippoCapom @mcgouveia_
Dimitrios Nasioudis retweeted
Gynecologic Oncology Advanced Surgical Course 10/18/25. @PennOBGYN @PennMedicine
For gyn onc fellows and attendings, a great hands-on cadaver course for high-yield surgical procedures, with post course benefits. You can register. med.upenn.edu/gynonc25/
Dimitrios Nasioudis retweeted
🔹 Only 1️⃣ in 5️⃣ women with node-positive #VulvarCancer received high-quality adjuvant RT —but if all RT quality metrics were met ✅, it increased their survival odds: 5-yr survival 🔼 from 43% ➡️ 63%! 👩⚕️✨
Read more @ bit.ly/458ZEiO
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @RParejaGineOnco @lchiv4 @annafagottimd @HousseinELHAJJ3 @AinhoaMada @HelenaObermair @sofiabigardiGMD @marina_rosanu @ChakraRim @FilippoCapom @mcgouveia_
#IJGConline #Research #Treatment #Diagnostic #GynCancer #GynOnc #WomenHealth #SoMe #SoMe4GynOnc
Dimitrios Nasioudis retweeted
Vaginal Estrogen Use in #breastcancer Survivors: A Systematic Review and Meta-Analysis of Recurrence and Mortality Risks @AJOG_thegray ajog.org/article/S0002-9378%…
No ⬆️ recurrences
No ⬆️ mortality
‼️Better #QoL‼️
@OncoAlert @weoncologists @GynMe4 @gyncsm @ESGO_society @IGCSociety
Dimitrios Nasioudis retweeted
Navigating DOAC dosing around surgeries?
@JAMA_current @OncoAlert #Anticoagulation #surgery #oncology
doi:10.1001/jama.2024.12708
Dimitrios Nasioudis retweeted
Impact of small-bite (5 mm) fascial closure on the incidence of incisional hernia following open colorectal cancer surgery: #RCT
➡️doi.org/10.1093/bjs/znae189
1⃣The small-bite suture technique reduced the development of incisional hernias in midline incisions after open colorectal cancer surgery by threefold compared with the conventional-bite technique
2⃣ The small-bite technique led to fewer surgical-site infections
Great work by Cumhur Ozcan, Tahsin Colak, Ozgur Turkmenoglu, Mustafa Berkesoglu, Elif Ertas
#SoMe4Surgery #MedTwitter #SurgEd #Surgery @RCPSGTrainees @aecirujanos @SEIQuirurgica @iss_sic #MedicalTechniques @BJSAcademy @young_bjs @BJSOpen @des_winter @evanscolorectal @robhinchliffe1 @bplwijn @ksoreide @MalinASund @nfmkok @TejedorPat @paulo_sutt @PVaughanShaw @JJEarnshaw @juliomayol @eurohernias #hernia #colorectalsurgery #StepUp4CRC @FightCRC @ACPGBI #ERAS @dice_europe #Crohn #proctology @Dukes_Club @ACPGBI_EduTrain @AECP_FAECP @PelvExGroup @escp_tweets @YouESCP
MOGCTs are rare #OvCAs with an overall excellent prognosis. #RecurrentDisease represents a challenge. We review available #evidence for the management of these pts. @PennMedicine @PennOBGYN @IJGCfellows ijgc.bmj.com/content/early/2…
Very excited for this continuation of the #BRIDGES program @gynoncjnls !!
‼️ New editorial 📄 program initiative between @gynoncjnls and #BRIDGES 🌉 scholars 👏 @SGO_org @GYNCancer @GOG @David_Cohn_MD @Doctor_Beryl @MMAlHilli @sy_rachel @LAURAJMOULTON @DNasioudis
Dimitrios Nasioudis retweeted
📣 📣 📣 Join us #IJGCclub
📆July 10
⏰11pm CDT/6pm CET
Hear @DNasioudis discuss the role of systematic #LND at the time of #IDS for patients with advanced-stage epithelial #OvarianCancer who achieved complete gross resection
Zoom link💻 bit.ly/3LjzP4h
Article @ bit.ly/4bBDSE8
Editorial @ bit.ly/4bsxsqN
Podcast @ bit.ly/3WgiuQp
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4
Dimitrios Nasioudis retweeted
#WeeklyPodcast Lymphadenectomy at the time of interval cytoreduction for #OvarianCancer with @DNasioudis
🎧 bit.ly/3WgiuQp
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4
Dimitrios Nasioudis retweeted
#ESMOGynae24: MIRASOL trial results show significant efficacy and safety benefits in patients w/ high folate receptor alpha, platinum-resistant ovarian cancer, even when treatment dose modifications are required.
#ESMODailyReporter 👉 ow.ly/GUBb50SmlTF
